Product Information
AZOPT 1% EYE DROPS is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $35.1697 per ML under NDC 00078072210. Its NADAC has been published 205 times since Mar 30, 2022.
FDA first approved this application on Apr 1, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078072210
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
2/18/2026
Active Ingredients
BRINZOLAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA020816FDA Approved
4/1/1998
TE Code
AB
On Market Since
4/30/1998
Pharmacological Classes
Price Statistics
The NADAC for AZOPT 1% EYE DROPS has been published 205 times since Mar 30, 2022, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $35.1697 per ML |
|---|---|
| All-time high | $35.4168 (Jul 10, 2024) |
| All-time low | $32.9151 (Mar 30, 2022) |
| 52-week high | $35.1812 |
| 52-week low | $35.1619 |
| Median price | $34.7220 |
| Average price | $34.7480 |
| Largest weekly change | +5.0% (Aug 3, 2022) |
| Weeks tracked | 205 |
| Tracking since | Mar 30, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-0.0%
3Y
+2.0%
5Y
N/A
All
+6.8%
Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novartis Pharmaceuticals Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
brinzolamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carbonic Anhydrase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZOPT 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for AZOPT 1% EYE DROPS, manufactured by Novartis Pharmaceuticals Corporation, is $35.1697 per ML (NDC 00078072210), effective Feb 25, 2026.
How has the price of AZOPT 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for AZOPT 1% EYE DROPS has risen 6.8%. It has been tracked across 205 weekly CMS publications since Mar 30, 2022.
What are the highest and lowest recorded NADAC prices for AZOPT 1% EYE DROPS?
Since Mar 30, 2022, the NADAC for AZOPT 1% EYE DROPS has ranged from a low of $32.9151 (Mar 30, 2022) to a high of $35.4168 (Jul 10, 2024), with a median of $34.7220 per ML.
Are there cheaper alternatives to AZOPT 1% EYE DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $8.5264 per ML — about 76% below AZOPT 1% EYE DROPS.
Who manufactures AZOPT 1% EYE DROPS?
AZOPT 1% EYE DROPS (NDC 00078072210) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.